Viewing Study NCT03389256


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-02 @ 6:10 PM
Study NCT ID: NCT03389256
Status: UNKNOWN
Last Update Posted: 2018-01-03
First Post: 2017-12-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sponsor: Sichuan Cancer Hospital and Research Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: APTN-NSCLC-201712
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View